{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:00:04Z","timestamp":1788303604268,"version":"build-2803163510"},"reference-count":137,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Proliferative vitreoretinopathy (PVR) is a severe fibrotic complication following ocular trauma or retinal detachment surgery, characterized by complex multicellular and multicytokine interactions. Its core mechanism involves retinal pigment epithelial (RPE) cells, glial cells, and inflammatory cells undergoing epithelial-mesenchymal transition (EMT), abnormal proliferation, migration, and contraction, ultimately leading to traction retinal detachment. Current treatment primarily relies on surgery, but faces limitations such as high postoperative recurrence rates and a lack of clinically approved effective adjuvant drugs. This review provides a comprehensive analysis of the PVR pathogenic network, integrating the roles of diverse cellular players with key signaling pathways. We place a particular emphasis on critically evaluating emerging therapeutic strategies, including targeted pathway inhibitors and, notably, innovative drug delivery systems, which represent a paradigm shift towards overcoming pharmacological barriers. By synthesizing mechanistic insights with translational applications, this article highlights current advances and underscores the gap between preclinical promise and clinical efficacy. It aims to serve as a timely resource for understanding the pathobiology of PVR and for guiding the development of future multi-targeted therapeutic interventions.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1774802","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T05:21:53Z","timestamp":1770700913000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["From fibrotic mechanisms to clinical translation: the drug therapy revolution and delivery system breakthrough in proliferative vitreoretinopathy"],"prefix":"10.3389","volume":"17","author":[{"given":"Zijian","family":"Chen","sequence":"first","affiliation":[{"name":"School of Optometry, Jiangxi Medical College, Nanchang University","place":["Nanchang, Jiangxi, China"]},{"name":"Jiangxi Research Institute of Ophthalmology and Visual Science","place":["Nanchang, Jiangxi, China"]},{"name":"Jiangxi Provincial Key Laboratory for Ophthalmology","place":["Nanchang, Jiangxi, China"]},{"name":"National Clinical Research Center for Ocular Diseases Jiangxi Province Division","place":["Nanchang, Jiangxi, China"]},{"name":"The Affiliated Eye Hospital, Jiangxi Medical College, Nanchang University","place":["Nanchang, Jiangxi, China"]},{"name":"Jiangxi Clinical Research Center for Ophthalmic Disease","place":["Nanchang, Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangying","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Optometry, Jiangxi Medical College, Nanchang University","place":["Nanchang, Jiangxi, China"]},{"name":"Jiangxi Research Institute of Ophthalmology and Visual Science","place":["Nanchang, Jiangxi, China"]},{"name":"Jiangxi Provincial Key Laboratory for Ophthalmology","place":["Nanchang, Jiangxi, China"]},{"name":"National Clinical Research Center for Ocular Diseases Jiangxi Province Division","place":["Nanchang, Jiangxi, China"]},{"name":"The Affiliated Eye Hospital, Jiangxi Medical College, Nanchang University","place":["Nanchang, Jiangxi, China"]},{"name":"Jiangxi Clinical Research Center for Ophthalmic Disease","place":["Nanchang, Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liao","family":"Quan","sequence":"additional","affiliation":[{"name":"School of Optometry, Jiangxi Medical College, Nanchang University","place":["Nanchang, Jiangxi, China"]},{"name":"Jiangxi Research Institute of Ophthalmology and Visual Science","place":["Nanchang, Jiangxi, China"]},{"name":"Jiangxi Provincial Key Laboratory for Ophthalmology","place":["Nanchang, Jiangxi, China"]},{"name":"National Clinical Research Center for Ocular Diseases Jiangxi Province Division","place":["Nanchang, Jiangxi, China"]},{"name":"The Affiliated Eye Hospital, Jiangxi Medical College, Nanchang University","place":["Nanchang, Jiangxi, China"]},{"name":"Jiangxi Clinical Research Center for Ophthalmic Disease","place":["Nanchang, Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingdan","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Optometry, Jiangxi Medical College, Nanchang University","place":["Nanchang, Jiangxi, China"]},{"name":"Jiangxi Research Institute of Ophthalmology and Visual Science","place":["Nanchang, Jiangxi, China"]},{"name":"Jiangxi Provincial Key Laboratory for Ophthalmology","place":["Nanchang, Jiangxi, China"]},{"name":"National Clinical Research Center for Ocular Diseases Jiangxi Province Division","place":["Nanchang, Jiangxi, China"]},{"name":"The Affiliated Eye Hospital, Jiangxi Medical College, Nanchang University","place":["Nanchang, Jiangxi, China"]},{"name":"Jiangxi Clinical Research Center for Ophthalmic Disease","place":["Nanchang, Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihua","family":"Xu","sequence":"additional","affiliation":[{"name":"School of Optometry, Jiangxi Medical College, Nanchang University","place":["Nanchang, Jiangxi, China"]},{"name":"Jiangxi Research Institute of Ophthalmology and Visual Science","place":["Nanchang, Jiangxi, China"]},{"name":"Jiangxi Provincial Key Laboratory for Ophthalmology","place":["Nanchang, Jiangxi, China"]},{"name":"National Clinical Research Center for Ocular Diseases Jiangxi Province Division","place":["Nanchang, Jiangxi, China"]},{"name":"The Affiliated Eye Hospital, Jiangxi Medical College, Nanchang University","place":["Nanchang, Jiangxi, China"]},{"name":"Jiangxi Clinical Research Center for Ophthalmic Disease","place":["Nanchang, Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"815937","DOI":"10.1155\/2012\/815937","article-title":"Mechanisms of inflammation in proliferative vitreoretinopathy: from bench to bedside","volume":"2012","author":"Moysidis","year":"2012","journal-title":"Mediators Inflamm"},{"key":"B2","article-title":"Mechanisms of epithelial-mesenchymal transition in proliferative vitreoretinopathy","volume":"20","author":"Yang","year":"2015","journal-title":"Discov Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0039-6257(98)00023-X","article-title":"Proliferative vitreoretinopathy: an overview","volume":"43","author":"Pastor","year":"1998","journal-title":"Surv Ophthalmol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-022-02401-7","article-title":"Recurrent retinal detachment after pars plana vitrectomy with silicone oil tamponade for rhegmatogenous retinal detachment","volume":"42","author":"Fu","year":"2022","journal-title":"Int Ophthalmol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"15419","DOI":"10.1038\/s41598-019-51633-8","article-title":"Characterisation of the inflammatory cytokine and growth factor profile in a rabbit model of proliferative vitreoretinopathy","volume":"9","author":"Wong","year":"2019","journal-title":"Sci Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200412000-00007","article-title":"Resources involved in managing retinal detachment complicated by proliferative vitreoretinopathy","volume":"24","author":"Patel","year":"2004","journal-title":"Retina"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/rb\/rbae081","article-title":"Exosomes-based dual drug-loaded nanocarrier for targeted and multiple proliferative vitreoretinopathy therapy","volume":"11","author":"Zhao","year":"2024","journal-title":"Regener Biomater"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00332-6","article-title":"Linking EMT programmes to normal and neoplastic epithelial stem cells","volume":"21","author":"Lambert","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2014.01.022","article-title":"Role of retinal pigment epithelial cell \u03b2-catenin signaling in experimental proliferative vitreoretinopathy","volume":"184","author":"Umazume","year":"2014","journal-title":"Am J Pathol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181630ece","article-title":"Inflammation, epithelial to mesenchymal transition, and epidermal growth factor receptor tyrosine kinase inhibitor resistance","volume":"3","author":"Krysan","year":"2008","journal-title":"J Thorac Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2174\/138945010791170860","article-title":"The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness","volume":"11","author":"Wang","year":"2010","journal-title":"Curr Drug Targ"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202402498RR","article-title":"Disintegrin rhodostomin mutant ameliorates the severity of experimental proliferative vitreoretinopathy by suppressing both integrin \u03b1v\u03b23 and \u03b15\u03b21","volume":"39","author":"Tsao","year":"2025","journal-title":"FASEB J"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1177\/11206721251343166","article-title":"Assessing the therapeutic potential of astaxanthin in experimental proliferative vitreoretinopathy models","volume":"35","author":"Sava\u015f","year":"2025","journal-title":"Eur J Ophthalmol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1167\/iovs.66.6.56","article-title":"Liposome encapsulation enhances ripasudil therapeutic efficacy against proliferative vitreoretinal diseases: implications in advanced ocular treatment","volume":"66","author":"Ji","year":"2025","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/s41598-025-85882-7","article-title":"Hirudo extract ameliorates proliferative vitreoretinopathy by promoting autophagy and attenuating the THBS2\/PI3K\/Akt pathway","volume":"15","author":"Huang","year":"2025","journal-title":"Sci Rep"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J Clin Invest"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.71040","article-title":"The role of adjunctive triamcinolone acetonide in post-traumatic vitreoretinal surgery: current insights and future perspectives","volume":"16","author":"Gandhi","year":"2024","journal-title":"Cureus"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2022.05.024","article-title":"Intravitreal 5-fluorouracil and heparin to prevent proliferative vitreoretinopathy: results from a randomized clinical trial","volume":"129","author":"Schaub","year":"2022","journal-title":"Ophthalmology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"269787","DOI":"10.1155\/2013\/269787","article-title":"Proliferative vitreoretinopathy after eye injuries: an overexpression of growth factors and cytokines leading to a retinal keloid","volume":"2013","author":"Morescalchi","year":"2013","journal-title":"Mediators Inflamm"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/bf00930309","article-title":"Immunohistochemistry of anterior proliferative vitreoretinopathy. Report of 11 cases","volume":"18","author":"St\u00f6dtler","year":"1994","journal-title":"Int Ophthalmol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"148039","DOI":"10.1155\/2012\/148039","article-title":"Proteomic analyses of the vitreous humour","volume":"2012","author":"Angi","year":"2012","journal-title":"Mediators Inflamm"},{"key":"B22","doi-asserted-by":"publisher","first-page":"110482","DOI":"10.1016\/j.exer.2025.110482","article-title":"Commonalities between fibrotic and inflammatory mechanisms in proliferative vitreoretinopathy and proliferative diabetic retinopathy","volume":"258","author":"Sreenivas Bk","year":"2025","journal-title":"Exp Eye Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"100846","DOI":"10.1016\/j.preteyeres.2020.100846","article-title":"The cell biology of the retinal pigment epithelium","volume":"24","author":"Lakkaraju","year":"2020","journal-title":"Prog Retin Eye Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"100969","DOI":"10.1016\/j.preteyeres.2021.100969","article-title":"The retinal pigment epithelium: Development, injury responses, and regenerative potential in mammalian and non-mammalian systems","volume":"85","author":"George","year":"2021","journal-title":"Prog Retin Eye Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/S1350-9462(01)00023-4","article-title":"Proliferative vitreoretinopathy: risk factors and pathobiology","volume":"21","author":"Pastor","year":"2002","journal-title":"Prog Retin Eye Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.14744\/bej.2020.28290","article-title":"Importance of m\u00fcller cells","volume":"5","author":"Kobat","year":"2020","journal-title":"Beyoglu Eye J"},{"key":"B27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.preteyeres.2004.07.001","article-title":"The role of M\u00fcller cells in fibrocontractive retinal disorders","volume":"24","author":"Guidry","year":"2005","journal-title":"Prog Retin Eye Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2014.07.001","article-title":"Extracellular matrix remodeling during retinal development","volume":"133","author":"Reinhard","year":"2015","journal-title":"Exp Eye Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/S0042-6989(02)00680-6","article-title":"M\u00fcller cell and neuronal remodeling in retinal detachment and reattachment and their potential consequences for visual recovery: a review and reconsideration of recent data","volume":"43","author":"Fisher","year":"2003","journal-title":"Vision Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(79)90468-9","article-title":"Method of production and natural history of experimental posterior penetrating eye injury in the rhesus monkey","volume":"88","author":"Cleary","year":"1979","journal-title":"Am J Ophthalmol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3892\/ijmm.2024.5446","article-title":"Role of microglia\/macrophage polarisation in intraocular diseases (Review)","volume":"53","author":"Li","year":"2024","journal-title":"Int J Mol Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40169-015-0047-4","article-title":"The significance of macrophage polarization subtypes for animal models of tissue fibrosis and human fibrotic diseases","volume":"4","author":"Wermuth","year":"2015","journal-title":"Clin Transl Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000371","article-title":"Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis","volume":"5","author":"Pesce","year":"2009","journal-title":"PloS Pathog"},{"key":"B34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/BF03403533","article-title":"Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair","volume":"1","author":"Bucala","year":"1994","journal-title":"Mol Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2010.03.004","article-title":"Fibrocytes in health and disease","volume":"38","author":"Herzog","year":"2010","journal-title":"Exp Hematol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-003-2328-0","article-title":"Fibrocytes: a unique cell population implicated in wound healing","volume":"60","author":"Metz","year":"2003","journal-title":"Cell Mol Life Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.12.7556","article-title":"Peripheral blood fibrocytes: differentiation pathway and migration to wound sites","volume":"166","author":"Abe","year":"2001","journal-title":"J Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.1.380","article-title":"Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma","volume":"171","author":"Schmidt","year":"2003","journal-title":"J Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"13510","DOI":"10.3390\/ijms241713510","article-title":"Macrophage-myofibroblast transition contributes to myofibroblast formation in proliferative vitreoretinal disorders","volume":"24","author":"Abu El-Asrar","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B40","article-title":"TGF-beta1, TGF-beta receptor II and ED-A fibronectin expression in myofibroblast of vitreoretinopathy","volume":"41","author":"Bochaton-Piallat","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-013-2531-0","article-title":"Myofibroblast and extracellular matrix origins in proliferative vitreoretinopathy","volume":"252","author":"Feist","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1136\/bjo.2007.134346","article-title":"Circulating fibrocytes contribute to the myofibroblast population in proliferative vitreoretinopathy epiretinal membranes","volume":"92","author":"Abu El-Asrar","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1167\/iovs.64.2.1","article-title":"Myo\/nog cells give rise to myofibroblasts during epiretinal membrane formation in a mouse model of proliferative vitreoretinopathy","volume":"64","author":"Crispin","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B44","doi-asserted-by":"publisher","first-page":"108080","DOI":"10.1016\/j.exer.2020.108080","article-title":"Myo\/Nog cells expressing muscle proteins are present in preretinal membranes from patients with proliferative vitreoretinopathy","volume":"197","author":"Gerhart","year":"2020","journal-title":"Exp Eye Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169744","article-title":"Role of myo\/nog cells in neuroprotection: evidence from the light damaged retina","volume":"12","author":"Brandli","year":"2017","journal-title":"PloS One"},{"key":"B46","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.preteyeres.2017.08.001","article-title":"Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis","volume":"60","author":"Shu","year":"2017","journal-title":"Prog Retin Eye Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"109085","DOI":"10.1016\/j.exer.2022.109085","article-title":"E-cadherin to N-cadherin switching in the TGF-\u03b21 mediated retinal pigment epithelial to mesenchymal transition","volume":"220","author":"Wei","year":"2022","journal-title":"Exp Eye Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/path.4104","article-title":"The myofibroblast matrix: implications for tissue repair and fibrosis","volume":"229","author":"Klingberg","year":"2013","journal-title":"J Pathol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(89)32817-x","article-title":"Immunostaining of preretinal membranes for actin, fibronectin, and glial fibrillary acidic protein","volume":"96","author":"Sramek","year":"1989","journal-title":"Ophthalmology"},{"key":"B50","article-title":"The role of fibronectin, laminin, vitronectin and their receptors on cellular adhesion in proliferative vitreoretinopathy","volume":"35","author":"Casaroli Marano","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)62353-X","article-title":"Regulation of alpha-smooth muscle actin expression in granulation tissue myofibroblasts is dependent on the intronic CArG element and the transforming growth factor-beta1 control element","volume":"166","author":"Tomasek","year":"2005","journal-title":"Am J Pathol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-0436.1988.tb00091.x","article-title":"Alpha-smooth muscle actin is transiently expressed in embryonic rat cardiac and skeletal muscles","volume":"39","author":"Woodcock-Mitchell","year":"1988","journal-title":"Differentiation"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2003.08.006","article-title":"Mechanisms of force generation and transmission by myofibroblasts","volume":"14","author":"Hinz","year":"2003","journal-title":"Curr Opin Biotechnol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e11-04-0335","article-title":"\u03b2-catenin and Smad3 regulate the activity and stability of myocardin-related transcription factor during epithelial-myofibroblast transition","volume":"22","author":"Charbonney","year":"2011","journal-title":"Mol Biol Cell"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2523","article-title":"Tightly anchored tissue-mimetic matrices as instructive stem cell microenvironments","volume":"10","author":"Prewitz","year":"2013","journal-title":"Nat Methods"},{"key":"B56","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.addr.2015.11.001","article-title":"Extracellular matrix structure","volume":"97","author":"Theocharis","year":"2016","journal-title":"Adv Drug Delivery Rev"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14302\/issn.2578-8590.ipj-17-1910","article-title":"Substrate stiffness influences the time dependence of CTGF protein expression in m\u00fcller cells","volume":"1","author":"Davis","year":"2018","journal-title":"Int Physiol J"},{"key":"B58","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nrm3904","article-title":"Remodelling the extracellular matrix in development and disease","volume":"15","author":"Bonnans","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.7.15.8262328","article-title":"Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis","volume":"7","author":"Stetler-Stevenson","year":"1993","journal-title":"FASEB J"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1006\/exer.1998.0585","article-title":"Predominance of MMP-1 and MMP-2 in epiretinal and subretinal membranes of proliferative vitreoretinopathy","volume":"68","author":"Webster","year":"1999","journal-title":"Exp Eye Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.114.4.629","article-title":"The cadherin superfamily: diversity in form and function","volume":"114","author":"Angst","year":"2001","journal-title":"J Cell Sci"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-2938","article-title":"Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways","volume":"68","author":"Onder","year":"2008","journal-title":"Cancer Res"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.09-4725","article-title":"Epithelial-mesenchymal transition and proliferation of retinal pigment epithelial cells initiated upon loss of cell-cell contact","volume":"51","author":"Tamiya","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2016.10.007","article-title":"Sec8 modulates TGF-\u03b2 induced EMT by controlling N-cadherin via regulation of Smad3\/4","volume":"29","author":"Tanaka","year":"2017","journal-title":"Cell Signal"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2018.05.016","article-title":"CD146 mediates an E-cadherin-to-N-cadherin switch during TGF-\u03b2 signaling-induced epithelial-mesenchymal transition","volume":"430","author":"Ma","year":"2018","journal-title":"Cancer Lett"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharep.2016.04.020","article-title":"Transforming growth factor \u03b2-related genes in human retinal pigment epithelial cells after tacrolimus treatment","volume":"68","author":"Kimsa","year":"2016","journal-title":"Pharmacol Rep"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1080\/08820538.2021.1890791","article-title":"Molecular targets for proliferative vitreoretinopathy","volume":"36","author":"Wu","year":"2021","journal-title":"Semin Ophthalmol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12943-022-01569-x","article-title":"Targeting TGF-\u03b2 signal transduction for fibrosis and cancer therapy","volume":"21","author":"Peng","year":"2022","journal-title":"Mol Cancer"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00501","article-title":"Role of epithelial-mesenchymal transition in retinal pigment epithelium dysfunction","volume":"8","author":"Zhou","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.pupt.2012.07.006","article-title":"Novel non-canonical TGF-\u03b2 signaling networks: emerging roles in airway smooth muscle phenotype and function","volume":"26","author":"Yeganeh","year":"2013","journal-title":"Pulm Pharmacol Ther"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.712124","article-title":"Canonical and non-canonical TGF\u03b2 Signaling activate autophagy in an ULK1-dependent manner","volume":"9","author":"Trelford","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2005.12.007","article-title":"Transforming growth factor beta2-induced myofibroblastic differentiation of human retinal pigment epithelial cells: regulation by extracellular matrix proteins and hepatocyte growth factor","volume":"83","author":"Gamulescu","year":"2006","journal-title":"Exp Eye Res"},{"key":"B73","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3892\/mmr.2021.12028","article-title":"Connective tissue growth factor promotes retinal pigment epithelium mesenchymal transition via the PI3K\/AKT signaling pathway","volume":"23","author":"Wang","year":"2021","journal-title":"Mol Med Rep"},{"key":"B74","doi-asserted-by":"publisher","first-page":"263","DOI":"10.21037\/atm.2020.03.86","article-title":"RPE epithelial-mesenchymal transition plays a critical role in the pathogenesis of proliferative vitreoretinopathy","volume":"8","author":"Li","year":"2020","journal-title":"Ann Transl Med"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(00)80244-5","article-title":"PDGF mediates a neuron-astrocyte interaction in the developing retina","volume":"17","author":"Fruttiger","year":"1996","journal-title":"Neuron"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2014.07.026","article-title":"Vascular endothelial growth factor acts primarily via platelet-derived growth factor receptor \u03b1 to promote proliferative vitreoretinopathy","volume":"184","author":"Pennock","year":"2014","journal-title":"Am J Pathol"},{"key":"B77","article-title":"An in vivo gene therapy approach for experimental proliferative vitreoretinopathy using the truncated platelet-derived growth factor alpha receptor","volume":"43","author":"Ikuno","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2008.10.020","article-title":"PDGF receptors are activated in human epiretinal membranes","volume":"88","author":"Cui","year":"2009","journal-title":"Exp Eye Res"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2012.0137","article-title":"Platelet-derived growth factor induced alpha-smooth muscle actin expression by human retinal pigment epithelium cell","volume":"29","author":"Si","year":"2013","journal-title":"J Ocul Pharmacol Ther"},{"key":"B80","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.3390\/jcm12165287","article-title":"Proliferative vitreoretinopathy: A reappraisal","volume":"12","author":"Carpineto","year":"2023","journal-title":"J Clin Med"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1159\/000086594","article-title":"Vascular endothelial growth factor levels in vitreous and serum of patients with either proliferative diabetic retinopathy or proliferative vitreoretinopathy","volume":"37","author":"Sydorova","year":"2005","journal-title":"Ophthalmic Res"},{"key":"B82","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.preteyeres.2013.12.006","article-title":"Is neutralizing vitreal growth factors a viable strategy to prevent proliferative vitreoretinopathy","volume":"40","author":"Pennock","year":"2014","journal-title":"Prog Retin Eye Res"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1159\/000027378","article-title":"Detection of vascular endothelial growth factor and tumor necrosis factor alpha in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker","volume":"212","author":"Armstrong","year":"1998","journal-title":"Ophthalmologica"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3109\/02713689409025133","article-title":"Distribution of cytokine proteins within epiretinal membranes in proliferative vitreoretinopathy","volume":"13","author":"Limb","year":"1994","journal-title":"Curr Eye Res"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0271950","article-title":"TNF-\u03b1 and NF-\u03baB signaling play a critical role in cigarette smoke-induced epithelial-mesenchymal transition of retinal pigment epithelial cells in proliferative vitreoretinopathy","volume":"17","author":"Wang","year":"2022","journal-title":"PloS One"},{"key":"B86","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s42003-019-0406-6","article-title":"P38 inhibition reverses TGF\u03b21 and TNF\u03b1-induced contraction in a model of proliferative vitreoretinopathy","volume":"2","author":"Schiff","year":"2019","journal-title":"Commun Biol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1080\/09273940490518900","article-title":"Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy","volume":"13","author":"Canataroglu","year":"2005","journal-title":"Ocul Immunol Inflamm"},{"key":"B88","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1076\/ceyr.26.1.9.14251","article-title":"Increased soluble interleukin-6 receptor in vitreous fluid of proliferative vitreoretinopathy","volume":"26","author":"Yamamoto","year":"2003","journal-title":"Curr Eye Res"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1159\/000072145","article-title":"Interleukin-8, nitric oxide and glutathione status in proliferative vitreoretinopathy and proliferative diabetic retinopathy","volume":"35","author":"Cicik","year":"2003","journal-title":"Ophthalmic Res"},{"key":"B90","article-title":"Interleukin-6 promotes proliferative vitreoretinopathy by inducing epithelial-mesenchymal transition via the JAK1\/STAT3 signaling pathway","volume":"26","author":"Chen","year":"2020","journal-title":"Mol Vis"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2014.02.012","article-title":"Comparison of interleukin-6 and matrix metalloproteinase expression in the subretinal fluid and the vitreous during proliferative vitreoretinopathy: correlations with extent, duration of RRD and PVR grade","volume":"67","author":"Symeonidis","year":"2014","journal-title":"Cytokine"},{"key":"B92","doi-asserted-by":"publisher","first-page":"22","DOI":"10.18240\/ijo.2023.01.04","article-title":"Intravitreal slow-release dexamethasone alleviates traumatic proliferative vitreoretinopathy by inhibiting persistent inflammation and M\u00fcller cell gliosis in rabbits","volume":"16","author":"Zhao","year":"2023","journal-title":"Int J Ophthalmol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1186\/1423-0127-17-s1-s27","article-title":"Effect of taurine chloramine on the production of matrix metalloproteinases (MMPs) in adiponectin- or IL-1beta-stimulated fibroblast-like synoviocytes","volume":"17","author":"Kim","year":"2010","journal-title":"J BioMed Sci"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-020-01325-4","article-title":"Inflammatory mediators of proliferative vitreoretinopathy: hypothesis and review","volume":"40","author":"Dai","year":"2020","journal-title":"Int Ophthalmol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"908468","DOI":"10.4061\/2011\/908468","article-title":"Recent advances in underlying pathologies provide insight into interleukin-8 expression-mediated inflammation and angiogenesis","volume":"2011","author":"Qazi","year":"2011","journal-title":"Int J Inflam"},{"key":"B96","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3390\/bioengineering10090998","article-title":"Substrate stiffness modulates TGF-\u03b2 Activation and ECM-associated gene expression in fibroblasts","volume":"10","author":"Verma","year":"2023","journal-title":"Bioeng (Basel)"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70374","article-title":"From growth factors to structure: PDGF and TGF-\u03b2 in granulation tissue formation","volume":"29","author":"Irma","year":"2025","journal-title":"A Lit Rev J Cell Mol Med"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2018.06.013","article-title":"Experimental proliferative vitreoretinopathy in rabbits by delivery of bioactive proteins with gelatin microspheres","volume":"129","author":"Hirose","year":"2018","journal-title":"Eur J Pharm Biopharm"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167684","article-title":"MicroRNA-182 Suppresses HGF\/SF-Induced Increases in Retinal Pigment Epithelial Cell Proliferation and Migration through Targeting c-Met","volume":"11","author":"Wang","year":"2016","journal-title":"PloS One"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0309539","article-title":"Survivin inhibition attenuates EGF-induced epithelial mesenchymal transformation of human RPE cells via the EGFR\/MAPK pathway","volume":"19","author":"Zhu","year":"2024","journal-title":"PloS One"},{"key":"B101","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/ncomms1734","article-title":"Activation of canonical Wnt signalling is required for TGF-\u03b2-mediated fibrosis","volume":"3","author":"Akhmetshina","year":"2012","journal-title":"Nat Commun"},{"key":"B102","doi-asserted-by":"publisher","first-page":"a022137","DOI":"10.1101\/cshperspect.a022137","article-title":"Signaling cross talk between TGF-\u03b2\/smad and other signaling pathways","volume":"9","author":"Luo","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2018.9713","article-title":"PI3K\/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (Review)","volume":"19","author":"Xie","year":"2019","journal-title":"Mol Med Rep"},{"key":"B104","doi-asserted-by":"publisher","first-page":"107884","DOI":"10.1016\/j.exer.2019.107884","article-title":"Idelalisib inhibits vitreous-induced Akt activation and proliferation of retinal pigment epithelial cells from epiretinal membranes","volume":"190","author":"Xin","year":"2020","journal-title":"Exp Eye Res"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA119.010130","article-title":"Phosphoinositide 3-kinase \u03b4 inactivation prevents vitreous-induced activation of AKT\/MDM2\/p53 and migration of retinal pigment epithelial cells","volume":"294","author":"Han","year":"2019","journal-title":"J Biol Chem"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1126\/science.284.5415.770","article-title":"Notch signaling: cell fate control and signal integration in development","volume":"284","author":"Artavanis-Tsakonas","year":"1999","journal-title":"Science"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2012.04.025","article-title":"Notch signaling pathway regulates proliferation and differentiation of immortalized M\u00fcller cells under hypoxic conditions in vitro","volume":"214","author":"Wang","year":"2012","journal-title":"Neuroscience"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1007\/s00418-016-1484-x","article-title":"Notch signaling modulates proliferative vitreoretinopathy via regulating retinal pigment epithelial-to-mesenchymal transition","volume":"147","author":"Zhang","year":"2017","journal-title":"Histochem Cell Biol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.7150\/thno.45192","article-title":"Targeting the Notch and TGF-\u03b2 signaling pathways to prevent retinal fibrosis in vitro and in vivo","volume":"10","author":"Fan","year":"2020","journal-title":"Theranostics"},{"key":"B110","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1038\/s41467-022-30474-6","article-title":"A bio-functional polymer that prevents retinal scarring through modulation of NRF2 signalling pathway","volume":"13","author":"Parikh","year":"2022","journal-title":"Nat Commun"},{"key":"B111","doi-asserted-by":"publisher","first-page":"20554","DOI":"10.1038\/s41598-020-77254-0","article-title":"Topical delivery of a small molecule RUNX1 transcription factor inhibitor for the treatment of proliferative vitreoretinopathy","volume":"10","author":"Delgado-Tirado","year":"2020","journal-title":"Sci Rep"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adh0994","article-title":"An mRNA-encoded dominant-negative inhibitor of transcription factor RUNX1 suppresses vitreoretinal disease in experimental models","volume":"16","author":"O\u2019Hare","year":"2024","journal-title":"Sci Transl Med"},{"key":"B113","doi-asserted-by":"publisher","first-page":"7324","DOI":"10.1038\/s41467-024-51624-y","article-title":"Multi-omics profiling of retinal pigment epithelium reveals enhancer-driven activation of RANK-NFATc1 signaling in traumatic proliferative vitreoretinopathy","volume":"15","author":"Liao","year":"2024","journal-title":"Nat Commun"},{"key":"B114","doi-asserted-by":"publisher","first-page":"11670","DOI":"10.3390\/ijms222111670","article-title":"Doxycycline ameliorates the severity of experimental proliferative vitreoretinopathy in mice","volume":"22","author":"Chen","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B115","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/15569527.2020.1730882","article-title":"Neferine inhibits epidermal growth factor-induced proliferation and migration of retinal pigment epithelial cells through downregulating p38 MAPK and PI3K\/AKT signalling","volume":"39","author":"Ozal","year":"2020","journal-title":"Cutan Ocul Toxicol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-025-03846-7","article-title":"Non-surgical interventions for proliferative vitreoretinopathy-a systematic review","volume":"39","author":"Hunter","year":"2025","journal-title":"Eye (Lond)"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.11-9119","article-title":"Intravitreal anti-VEGF therapy blocks inflammatory cell infiltration and re-entry into the circulation in retinal angiogenesis","volume":"53","author":"Nakao","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.124636","article-title":"Syndecan-4 signaling at a glance","volume":"126","author":"Elfenbein","year":"2013","journal-title":"J Cell Sci"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.01.021","article-title":"Slow-release dexamethasone in proliferative vitreoretinopathy: A prospective, randomized controlled clinical trial","volume":"124","author":"Banerjee","year":"2017","journal-title":"Ophthalmology"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/GNBJ1387","article-title":"A randomised controlled trial of adjunctive triamcinolone acetonide in eyes undergoing vitreoretinal surgery for open globe trauma - the ASCOT study","volume":"27","author":"Charteris","year":"2023","journal-title":"Health Technol Assess"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-024-06665-w","article-title":"Intravitreal methotrexate as an adjuvant in vitrectomy in cases of retinal detachment with proliferative vitreoretinopathy","volume":"263","author":"Rajan","year":"2025","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.ophtha.2006.08.042","article-title":"Randomized controlled trial of combined 5-Fluorouracil and low-molecular-weight heparin in the management of unselected rhegmatogenous retinal detachments undergoing primary vitrectomy","volume":"114","author":"Wickham","year":"2007","journal-title":"Ophthalmology"},{"key":"B123","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/S0008-4182(05)80052-3","article-title":"Intravitreal triamcinolone for treatment of complicated proliferative diabetic retinopathy and proliferative vitreoretinopathy","volume":"40","author":"Munir","year":"2005","journal-title":"Can J Ophthalmol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14735","article-title":"Comparative cytotoxic and antiproliferative profile of methotrexate and fluorouracil on different ocular cells","volume":"99","author":"Schulz","year":"2021","journal-title":"Acta Ophthalmol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"108843","DOI":"10.1016\/j.exer.2021.108843","article-title":"Demethoxycurcumin inhibits the cell migration and MMP-2 expression in human retinal pigment epithelial cells by targeting the STAT-3 pathway","volume":"213","author":"Wang","year":"2021","journal-title":"Exp Eye Res"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2018.11.001","article-title":"Crocetin inhibits PDGF-BB-induced proliferation and migration of retinal pigment epithelial cells","volume":"842","author":"Zhang","year":"2019","journal-title":"Eur J Pharmacol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"197","DOI":"10.18240\/ijo.2022.02.02","article-title":"Artesunate inhibits proliferation and migration of RPE cells and TGF-\u03b22 mediated epithelial mesenchymal transition by suppressing PI3K\/AKT pathway","volume":"15","author":"Wang","year":"2022","journal-title":"Int J Ophthalmol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"108859","DOI":"10.1016\/j.exer.2021.108859","article-title":"Artesunate inhibits the development of PVR by suppressing the TGF-\u03b2\/Smad signaling pathway","volume":"213","author":"Wang","year":"2021","journal-title":"Exp Eye Res"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.15-18330","article-title":"Short pulse of clinical concentration of bevacizumab modulates human retinal pigment epithelial functionality","volume":"57","author":"Subramani","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B130","doi-asserted-by":"publisher","first-page":"43736","DOI":"10.1038\/srep43736","article-title":"Inhibition of proliferation and epithelial mesenchymal transition in retinal pigment epithelial cells by heavy chain-hyaluronan\/pentraxin 3","volume":"7","author":"He","year":"2017","journal-title":"Sci Rep"},{"key":"B131","doi-asserted-by":"publisher","first-page":"8720","DOI":"10.3390\/ijms25168720","article-title":"Nano-based drug approaches to proliferative vitreoretinopathy instead of standard vitreoretinal surgery","volume":"25","author":"Sorrentino","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B132","doi-asserted-by":"publisher","first-page":"120226","DOI":"10.1016\/j.ijpharm.2021.120226","article-title":"Safety assessment of polymeric micelles as an ophthalmic drug delivery system for intravitreal administration of dasatinib","volume":"596","author":"Li","year":"2021","journal-title":"Int J Pharm"},{"key":"B133","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jconrel.2021.03.023","article-title":"Controlled release of triamcinolone from an episcleral micro film delivery system for open-globe eye injuries and proliferative vitreoretinopathy","volume":"333","author":"Wu","year":"2021","journal-title":"J Ctrl Rel"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2020.1833382","article-title":"A sustained dual drug delivery system for proliferative vitreoretinopathy","volume":"27","author":"Xiao","year":"2020","journal-title":"Drug Deliv"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.a.36995","article-title":"Self-assembling hydrogel loaded with 5-FU PLGA microspheres as a novel vitreous substitute for proliferative vitreoretinopathy","volume":"108","author":"Yu","year":"2020","journal-title":"J BioMed Mater Res A"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2017.1399303","article-title":"A novel lipid prodrug strategy for sustained delivery of hexadecyloxypropyl 9-[2-(phosphonomethoxy)ethyl]guanine (HDP-PMEG) on unwanted ocular proliferation","volume":"24","author":"Chen","year":"2017","journal-title":"Drug Deliv"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2017.10.109","article-title":"Retinoic acid-loaded alginate microspheres as a slow release drug delivery carrier for intravitreal treatment","volume":"97","author":"Wang","year":"2018","journal-title":"BioMed Pharmacother"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1774802\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T10:00:13Z","timestamp":1771927213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1774802\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":137,"alternative-id":["10.3389\/fimmu.2026.1774802"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1774802","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]},"article-number":"1774802"}}